B-type natriuretic peptide/ferritin ratio as a predictor of the risk of developing acute renal injury in acute decompensated heart failure

ArticleAçık Erişim

Özet

OBJECTIVES: Acute decompensated heart failure (ADHF) is a clinical condition that requires urgent diagnosis and treatment. Patients present with pulmonary capillary wedge pressure, pulmonary arterial pressure, and venous pressure elevation. Along with the progressive deterioration observed in the clinical picture, impairment or deterioration of kidney function may also occur. In this study, we evaluated the B-type natriuretic peptide (BNP)/ferritin ratio as a predictor of the risk of developing acute renal injury (ARI) in ADHF. METHODS: A total of 157 patients with a diagnosis of ischemic dilated cardiomyopathy for more than 6 months that presented to our clinic with ADHF were included in this cohort study. After the treatment protocol was applied, the sample was divided into two groups as patients with and without ARI. The BNP and ferritin levels were examined along with the routine blood parameters (BNP), and the BNP, ferritin, and BNP/ferritin values were compared between the groups. RESULTS: ARI was present in 34.3% (n = 54) of the patients, who were also found to have higher BNP (892.76 vs. 817.54), lower ferritin (86.78 ± 57.2 vs. 105.46 ± 38.3), and higher BNP/ferritin (10.48 ± 2.14 vs. 7.89 ± 1.89). The multivariate logistic regression analysis revealed the BNP/ferritin ratio as an independent risk factor for ARI (odds ratio = 3.19; 95% CI, 1.92-6.54; P = 0.001). Using the receiver operating characteristic curve, a cutoff value of 9.32 for BNP/ferritin ratio had a sensitivity of 81.8% and a specificity of 93.5% (area under the curve 0.842, P < 0.001) for the prediction of ARI. CONCLUSION: The BNP/ferritin ratio is a new parameter that can be used to draw attention to the severity of the treatment and renal function in ADHF cases in emergency situations. © 2021 Emergency Medicine Association of Turkey. All rights reserved.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/13114Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.4103/2452-2473.320801Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorCeyhun, Gökhan
dc.contributor.authorÖztürk, Mustafa
dc.contributor.authorKüçüksu, Zafer
dc.contributor.authorAydin, Sidar
dc.contributor.authorÖzkoç, Mustafa
dc.contributor.authorAltinkaya, Onur
dc.contributor.authorAteş, Azman
dc.date.accessioned2026-10-18T20:27:57.366321922Z
dc.date.available2026-10-18T20:27:57.366321922Z
dc.date.issued2021
dc.description.abstractOBJECTIVES: Acute decompensated heart failure (ADHF) is a clinical condition that requires urgent diagnosis and treatment. Patients present with pulmonary capillary wedge pressure, pulmonary arterial pressure, and venous pressure elevation. Along with the progressive deterioration observed in the clinical picture, impairment or deterioration of kidney function may also occur. In this study, we evaluated the B-type natriuretic peptide (BNP)/ferritin ratio as a predictor of the risk of developing acute renal injury (ARI) in ADHF. METHODS: A total of 157 patients with a diagnosis of ischemic dilated cardiomyopathy for more than 6 months that presented to our clinic with ADHF were included in this cohort study. After the treatment protocol was applied, the sample was divided into two groups as patients with and without ARI. The BNP and ferritin levels were examined along with the routine blood parameters (BNP), and the BNP, ferritin, and BNP/ferritin values were compared between the groups. RESULTS: ARI was present in 34.3% (n = 54) of the patients, who were also found to have higher BNP (892.76 vs. 817.54), lower ferritin (86.78 ± 57.2 vs. 105.46 ± 38.3), and higher BNP/ferritin (10.48 ± 2.14 vs. 7.89 ± 1.89). The multivariate logistic regression analysis revealed the BNP/ferritin ratio as an independent risk factor for ARI (odds ratio = 3.19; 95% CI, 1.92-6.54; P = 0.001). Using the receiver operating characteristic curve, a cutoff value of 9.32 for BNP/ferritin ratio had a sensitivity of 81.8% and a specificity of 93.5% (area under the curve 0.842, P < 0.001) for the prediction of ARI. CONCLUSION: The BNP/ferritin ratio is a new parameter that can be used to draw attention to the severity of the treatment and renal function in ADHF cases in emergency situations. © 2021 Emergency Medicine Association of Turkey. All rights reserved.
dc.identifier.doi10.4103/2452-2473.320801
dc.identifier.endpage103
dc.identifier.issn2452-2473
dc.identifier.issue3
dc.identifier.pmcidPMC8330609
dc.identifier.pmid34377865
dc.identifier.scopus2-s2.0-85111028909
dc.identifier.startpage98
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/13114
dc.identifier.volume21
dc.identifier.wosWOS:000675015900002
dc.language.isoen
dc.publisherWolters Kluwer Medknow Publications
dc.relation.ispartofTurkish Journal of Emergency Medicine
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectB-type natriuretic peptide/ferritin ratio
dc.subjectheart failure
dc.subjectrenal injury
dc.subjectalbumin
dc.subjectbrain natriuretic peptide
dc.subjectcreatinine
dc.subjectferritin
dc.subjectglucose
dc.subjectprotein
dc.subjecttroponin I
dc.subjectacute heart failure
dc.subjectacute kidney failure
dc.subjectadult
dc.subjectArticle
dc.subjectb type natriuretic peptide ferritin ratio
dc.subjectblood cell count
dc.subjectcohort analysis
dc.subjectconcentration (parameter)
dc.subjectcongestive cardiomyopathy
dc.subjectcontrolled study
dc.subjectdiagnostic accuracy
dc.subjectestimated glomerular filtration rate
dc.subjectfemale
dc.subjectferritin blood level
dc.subjectglucose blood level
dc.subjecthuman
dc.subjectlipid fingerprinting
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmultivariate logistic regression analysis
dc.titleB-type natriuretic peptide/ferritin ratio as a predictor of the risk of developing acute renal injury in acute decompensated heart failure
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus1
rdl.citation.wos1
rdl.departmentDepartment of Cardiology, Medical Faculty, Atatürk University, Erzincan, Turkey. | Department of Cardiology, University of Health Sciences, Erzurum Education and Research Hospital, Erzincan, Turkey. | Department of Cardiology, Erzincan University Mengucek Gazi Research and Training Hospital, Erzincan, Turkey. | Department of Cardiovascular Surgery, Medical Faculty, Atatürk University, Erzincan, Turkey.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexEmerging Sources Citation Index (ESCI)